tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Technical Analysis

1,948 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Aquestive Therapeutics’s (AQST) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Aquestive Therapeutics is a Sell.
Aquestive Therapeutics’s (AQST) 20-Day exponential moving average is 2.80, while Aquestive Therapeutics’s (AQST) share price is $3.18, making it a Buy.
Aquestive Therapeutics’s (AQST) 50-Day exponential moving average is 2.91, while Aquestive Therapeutics’s (AQST) share price is $3.18, making it a Buy.

Aquestive Therapeutics (AQST) Pivot Points

Jul 23, 2024, 05:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.93
2.99
3.09
3.16
3.26
3.32
3.43
Fibonacci
2.99
3.05
3.09
3.16
3.22
3.26
3.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aquestive Therapeutics (AQST) Moving Averages

Jul 23, 2024, 05:47 PM
Period
Simple
Exponential
MA5
3.09Sell
3.03Buy
MA10
2.85Buy
2.91Buy
MA20
2.65Buy
2.80Buy
MA50
2.84Buy
2.91Buy
MA100
3.54Sell
3.03Buy
MA200
2.81Buy
2.65Buy
Aquestive Therapeutics’s (AQST) 10-Day exponential moving average is 2.91, while Aquestive Therapeutics’s (AQST) share price is $3.18, making it a Buy.
Aquestive Therapeutics’s (AQST) 100-Day exponential moving average is 3.03, while Aquestive Therapeutics’s (AQST) share price is $3.18, making it a Buy.
Aquestive Therapeutics’s (AQST) stock price is $3.18 and Aquestive Therapeutics’s (AQST) 50-day simple moving average is 2.84, creating a Buy signal.
Aquestive Therapeutics’s (AQST) stock price is $3.18 and Aquestive Therapeutics’s (AQST) 100-day simple moving average is 3.54, creating a Sell signal.
Aquestive Therapeutics’s (AQST) stock price is $3.18 and Aquestive Therapeutics’s (AQST) 200-day simple moving average is 2.81, creating a Buy signal.

Aquestive Therapeutics (AQST) Technical Indicators

Jul 23, 2024, 05:47 PM
Name
Value
Implied Action
RSI (14)
58.73
Neutral
STOCH (9,6)
77.72
Neutral
STOCHRSI (14)
78.62
Neutral
MACD (12,26)
0.07
Sell
ADX (14)
32.54
Neutral
Williams %R
-28.72
Buy
CCI (14)
122.26
Sell
ATR (14)
0.20
-
Ultimate Oscillator
51.84
Neutral
ROC
23.67
Buy
Aquestive Therapeutics’s (AQST) Relative Strength Index (RSI) is 58.73, creating a Neutral signal.
Aquestive Therapeutics’s (AQST) Trend Strength Indicator (ADX) is 32.54, creating a Neutral signal.
Aquestive Therapeutics’s (AQST) Commodity Channel Index (CCI) is 122.26, creating a Sell signal.
Aquestive Therapeutics’s (AQST) Price Rate of Change (ROC) is 23.67, creating a Buy signal.

FAQ

Is AQST a Buy, Hold, or Sell?
Based on AQST’s technical indicators, AQST is a Buy.
    What is AQST’s RSI (14)?
    AQST’s RSI (14) is 58.73, which suggests AQST is a Neutral.
      What is AQST’s MACD?
      AQST’s MACD is 0.07, which suggests AQST is a Sell.
        What is AQST’s 5-day moving average?
        AQST’s 5-day moving average is 3.09, which suggests AQST is a Sell.
          What is AQST’s 20-day moving average?
          AQST 20-day moving average is 2.65, which suggests AQST is a Buy.
            What is AQST’s 50-day moving average?
            AQST’s 50-day moving average is 2.84, which suggests AQST is a Buy.
              What is AQST’s 200-day moving average?
              AQST’s 200-day moving average is 2.81, which suggests AQST is a Buy.
                What is AQST’s Williams % R (14)?
                AQST’s Williams % R (14) is -28.72, which suggests AQST is a Buy.
                  What is AQST’s CCI (14)?
                  AQST’s CCI (14) is 122.26, which suggests AQST is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis